Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision

  1. James A Watson  Is a corresponding author
  2. Carolyne M Ndila
  3. Sophie Uyoga
  4. Alexander Macharia
  5. Gideon Nyutu
  6. Shebe Mohammed
  7. Caroline Ngetsa
  8. Neema Mturi
  9. Norbert Peshu
  10. Benjamin Tsofa
  11. Kirk Rockett
  12. Stije Leopold
  13. Hugh Kingston
  14. Elizabeth C George
  15. Kathryn Maitland
  16. Nicholas PJ Day
  17. Arjen M Dondorp
  18. Philip Bejon
  19. Thomas Williams
  20. Chris C Holmes
  21. Nicholas J White
  1. Mahidol Oxford Tropical Medicine Research Unit, Thailand
  2. KEMRI-Wellcome Trust Research Programme, Kenya
  3. Kenya Medical Research Institute-Wellcome Trust Research Programme, Kenya
  4. Wellcome Trust Centre for Human Genetics, United Kingdom
  5. Medical Research Council Clinical Trials Unit, United Kingdom
  6. Mahidol University, Thailand
  7. Kilifi KEMRI-Wellcome Trust Collaborative Research Programme, Kenya
  8. Department of Statistics, University of Oxford, United Kingdom

Abstract

Severe falciparum malaria has substantially affected human evolution. Genetic association studies of patients with clinically defined severe malaria and matched population controls have helped characterise human genetic susceptibility to severe malaria, but phenotypic imprecision compromises discovered associations. In areas of high malaria transmission the diagnosis of severe malaria in young children and, in particular, the distinction from bacterial sepsis, is imprecise. We developed a probabilistic diagnostic model of severe malaria using platelet and white count data. Under this model we re-analysed clinical and genetic data from 2,220 Kenyan children with clinically defined severe malaria and 3,940 population controls, adjusting for phenotype mis-labelling. Our model, validated by the distribution of sickle trait, estimated that approximately one third of cases did not have severe malaria. We propose a data-tilting approach for case-control studies with phenotype mis-labelling and show that this reduces false discovery rates and improves statistical power in genome-wide association studies.

Data availability

A curated minimal clinical dataset is currently available alongisde the code on the github repository. This will also be made available at publication via the KEMRI-Wellcome Harvard Dataverse(https://dataverse.harvard.edu/dataverse/kwtrp).Whole genome data are available from European Genome-Phenome Archive (dataset accession ID: EGAD00010001742).Requests for access to appropriately anonymized clinical data and directly typed genetic variants for the Kenyan severe malaria cohort can be made by application to the data access committee at the KEMRI-Wellcome Trust Research Programme by e-mail to mmunene@kemri-wellcome.org.The FEAST trial datasets are available from the principal investigator on reasonable request (k.maitland@imperial.ac.uk).Requests for access to appropriately anonymized clinical data from the AQ and AAV Vietnam study and the Asian paediatric cohort can be made via the Mahidol Oxford Tropical Medicine Research Unit data access committee by emailing the corresponding author JAW (jwatowatson@gmail.com) or Rita Chanviriyavuth (rita@tropmedres.ac).

The following previously published data sets were used

Article and author information

Author details

  1. James A Watson

    Malaria, Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
    For correspondence
    jwatowatson@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5524-0325
  2. Carolyne M Ndila

    KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  3. Sophie Uyoga

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  4. Alexander Macharia

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  5. Gideon Nyutu

    KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  6. Shebe Mohammed

    KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  7. Caroline Ngetsa

    KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  8. Neema Mturi

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  9. Norbert Peshu

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  10. Benjamin Tsofa

    KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  11. Kirk Rockett

    Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Stije Leopold

    Malaria, Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0482-5689
  13. Hugh Kingston

    Malaria, Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1869-8307
  14. Elizabeth C George

    Medical Research Council Clinical Trials Unit, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  15. Kathryn Maitland

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0007-0645
  16. Nicholas PJ Day

    Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2309-1171
  17. Arjen M Dondorp

    Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5190-2395
  18. Philip Bejon

    Pathogen Vector Host Biology, Kilifi KEMRI-Wellcome Trust Collaborative Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  19. Thomas Williams

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4456-2382
  20. Chris C Holmes

    Department of Statistics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  21. Nicholas J White

    Malaria, Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1897-1978

Funding

Wellcome Trust (209265/Z/17/Z)

  • Kathryn Maitland
  • Nicholas PJ Day

Wellcome Trust (202800/Z/16/Z)

  • Thomas Williams

Wellcome Trust (093956/Z/10/C)

  • Nicholas J White

Medical Research Council (MC\UU\12023/26)

  • Elizabeth C George

Wellcome Trust (WT077383/Z/05/Z)

  • Kirk Rockett

Medical Research Council (G0801439)

  • Elizabeth C George
  • Kathryn Maitland

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All clinical data are from published studies in which all participants or guardians gave fully informed consent. Access to the human genetic data was approved by the MalariaGen data access committee.

Copyright

© 2021, Watson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,046
    views
  • 128
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. James A Watson
  2. Carolyne M Ndila
  3. Sophie Uyoga
  4. Alexander Macharia
  5. Gideon Nyutu
  6. Shebe Mohammed
  7. Caroline Ngetsa
  8. Neema Mturi
  9. Norbert Peshu
  10. Benjamin Tsofa
  11. Kirk Rockett
  12. Stije Leopold
  13. Hugh Kingston
  14. Elizabeth C George
  15. Kathryn Maitland
  16. Nicholas PJ Day
  17. Arjen M Dondorp
  18. Philip Bejon
  19. Thomas Williams
  20. Chris C Holmes
  21. Nicholas J White
(2021)
Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision
eLife 10:e69698.
https://doi.org/10.7554/eLife.69698

Share this article

https://doi.org/10.7554/eLife.69698

Further reading

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Felix Lankester, Tito J Kibona ... Sarah Cleaveland
    Research Article

    Lack of data on the aetiology of livestock diseases constrains effective interventions to improve livelihoods, food security and public health. Livestock abortion is an important disease syndrome affecting productivity and public health. Several pathogens are associated with livestock abortions but across Africa surveillance data rarely include information from abortions, little is known about aetiology and impacts, and data are not available to inform interventions. This paper describes outcomes from a surveillance platform established in Tanzania spanning pastoral, agropastoral and smallholder systems to investigate causes and impacts of livestock abortion. Abortion events were reported by farmers to livestock field officers (LFO) and on to investigation teams. Events were included if the research team or LFO could attend within 72 hr. If so, samples and questionnaire data were collected to investigate (a) determinants of attribution; (b) patterns of events, including species and breed, previous abortion history, and seasonality; (c) determinants of reporting, investigation and attribution; (d) cases involving zoonotic pathogens. Between 2017–2019, 215 events in cattle (n=71), sheep (n=44), and goats (n=100) were investigated. Attribution, achieved for 19.5% of cases, was significantly affected by delays in obtaining samples. Histopathology proved less useful than PCR due to rapid deterioration of samples. Vaginal swabs provided practical and sensitive material for pathogen detection. Livestock abortion surveillance, even at a small scale, can generate valuable information on causes of disease outbreaks, reproductive losses and can identify pathogens not easily captured through other forms of livestock disease surveillance. This study demonstrated the feasibility of establishing a surveillance system, achieved through engagement of community-based field officers, establishment of practical sample collection and application of molecular diagnostic platforms.

    1. Epidemiology and Global Health
    2. Genetics and Genomics
    Tianyu Zhao, Hui Li ... Li Chen
    Research Article

    Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system, and elucidating its pathogenesis remains challenging. In this study, we used the inverse-variance weighted (IVW) model as the major analysis method to perform hypothesis-free Mendelian randomization (MR) analysis on the data from MRC IEU OpenGWAS (18,097 exposure traits and 16 AD outcome traits), and conducted sensitivity analysis with six models, to assess the robustness of the IVW results, to identify various classes of risk or protective factors for AD, early-onset AD, and late-onset AD. We generated 400,274 data entries in total, among which the major analysis method of the IVW model consists of 73,129 records with 4840 exposure traits, which fall into 10 categories: Disease, Medical laboratory science, Imaging, Anthropometric, Treatment, Molecular trait, Gut microbiota, Past history, Family history, and Lifestyle trait. More importantly, a freely accessed online platform called MRAD (https://gwasmrad.com/mrad/) has been developed using the Shiny package with MR analysis results. Additionally, novel potential AD therapeutic targets (CD33, TBCA, VPS29, GNAI3, PSME1) are identified, among which CD33 was positively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. TBCA and VPS29 were negatively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. GNAI3 and PSME1 were negatively associated with the main outcome traits of AD, as well as with LOAD, but had no significant causal association with EOAD. The findings of our research advance our understanding of the etiology of AD.